Trial intelligence / Profile preview

Alectinib adjuvant therapy versus platinum-based chemotherapy after complete resection in ALK-positive non-small cell lung cancer

CTR20182000Phase 3Active

Sponsor

Roche

Start

Jun 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1